Bangladesh, being densely populated, with more than 1,000 people living per square kilometre, continues to be a challenging context for control of TB. The rise of antimicrobial resistance raises the bar.
An article in VaccinesWork elaborates on the mounting problem of drug-resistant TB in the country and how the National TB Control Program responds.